Melanie Swan

Melanie Swan is a philosopher and economic theorist who has worked in various fields, including academic research, finance, and entrepreneurship. She has an MBA in Finance from the Wharton School at the University of Pennsylvania, an MA in Contemporary Continental Philosophy from Kingston University London and Université Paris 8, and a BA in French and Economics from Georgetown University. She is also a PhD candidate in Information Systems Biology at the Centre for Blockchain Technologies at University College London.

Swan is the founder of several startups, including the Institute for Blockchain Studies, DIYgenomics, GroupPurchase, and the MS Futures Group. Her research interests focus on emerging science and technology, particularly as directed towards biology, at the level of conceptual advance. She has currently focused on information systems biology approaches to biological risk management, DIYgenomics crowdsourced healthy cohort studies, and mathematical physics, quantum computation, and blockchain technologies applied to the multiscalar ecosystem study of precision health, disease, and ageing.

Swan is an instructor at Singularity University, an Affiliate Scholar at the Institute for Ethics and Emerging Technologies, and a contributor to the Edge's Annual Essay Question. She has also served as an advisor to research foundations, government agencies, corporations, and startups. In addition, she has designed collaboration simulations including "Discontinuity Futures," "Being an Entrepreneur" and "The Trader's Pit." She has published several books on topics such as blockchain economics, quantum computing, and the blockchain.

Melanie Swan is a philosopher, economic theorist, and entrepreneur known for her work in emerging science and technology. She was born in California, USA, and has an MBA in Finance from the Wharton School at the University of Pennsylvania, an MA in Contemporary Continental Philosophy from Kingston University London and Université Paris 8, and a BA in French and Economics from Georgetown University.

Swan's career has spanned academic research, finance, and entrepreneurship. She has held management and finance positions at J.P. Morgan in New York, Fidelity in Boston, and Arthur Andersen in Los Angeles. She served as the Director of Research at Telecoms Consultancy Ovum RHK, and she is currently a Research Associate at the Centre for Blockchain Technologies at University College London.

Swan is the founder of several startups, including the Institute for Blockchain Studies, DIYgenomics, GroupPurchase, and the MS Futures Group. She is a faculty member at Singularity University and the University of the Commons, an Affiliate Scholar at the Institute for Ethics and Emerging Technologies, and a contributor to the Edge's Annual Essay Question.

Swan's research interests focus on emerging science and technology, particularly as directed towards biology, at the level of conceptual advance. She has currently focused on information systems biology approaches to biological risk management, DIYgenomics crowdsourced healthy cohort studies, and mathematical physics, quantum computation, and blockchain technologies applied to the multiscalar ecosystem study of precision health, disease, and ageing.

In addition to her research and entrepreneurship, Swan is an accomplished author. She has published several books on topics such as blockchain economics, quantum computing, and the blockchain. She is also a workshop presenter at the Expanding Your Horizons math and science conference and has served as the Treasurer of the San Francisco-based non-profit Equal Rights Advocates.

Melanie Swan's vision is to explore and develop new technologies and methodologies to solve complex problems related to biology, health, and aging. She believes that by combining emerging technologies such as blockchain, quantum computing, and information systems biology, we can create a more efficient and effective healthcare system that is focused on individualized precision medicine.

Swan also advocates for democratizing access to healthcare and research, and she has founded several startups and organizations aimed at this goal. DIYgenomics, for example, is a crowdsourced health research study that allows individuals to contribute their own genetic data to research projects. GroupPurchase is another startup that aims to lower the cost of healthcare by allowing groups of people to pool their resources and negotiate directly with healthcare providers.